eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Cephalon (UK) Limited

Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 25/10/2010
PIL Erymax Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 20/07/2010 and displayed until 25/10/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/06/2010 and displayed until 20/07/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to drug interactions
Updated on 29/04/2010 and displayed until 21/06/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 09/04/2010 and displayed until 29/04/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 11/02/2009 and displayed until 09/04/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/09/2008 and displayed until 11/02/2009
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 30/07/2008 and displayed until 04/09/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 03/06/2008 and displayed until 30/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/10/2007 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 01/08/2006 and displayed until 24/10/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/08/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   erythromycin